Medication
Letrozole
DIN 02504472 · Sanis Health Inc Likely a generic
What it is
- Active ingredients
- Letrozole — 2.5 mg
- Form and route
- Tablet · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2021-03-19
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Femara
- PMS-Letrozole
- Ach-Letrozole
- Teva-Letrozole
- Sandoz Letrozole
- Apo-Letrozole
- Mar-Letrozole
- Bio-Letrozole
- Riva-Letrozole
- Letrozole
- Nat-Letrozole
- Mint-Letrozole
- Nra-Letrozole
- Letrozole
- Jamp Letrozole Tablets
- AG-Letrozole Tablets
- M-Letrozole
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Antineoplastic and immunomodulating agents
- ATC code
- L02BG04
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of L02BG04, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.